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To obtain new information about Streptococcus pyogenes intrahost genetic variation during invasive infection, we sequenced the
genomes of 2,954 serotype M1 strains recovered from a nonhuman primate experimental model of necrotizing fasciitis. A total
of 644 strains (21.8%) acquired polymorphisms relative to the input parental strain. The fabT gene, encoding a transcriptional
regulator of fatty acid biosynthesis genes, contained 54.5% of these changes. The great majority of polymorphisms were pre-
dicted to deleteriously alter FabT function. Transcriptome-sequencing (RNA-seq) analysis of a wild-type strain and an isogenic
fabT deletion mutant strain found that between 3.7 and 28.5% of the S. pyogenes transcripts were differentially expressed, de-
pending on the growth temperature (35°C or 40°C) and growth phase (mid-exponential or stationary phase). Genes implicated
in fatty acid synthesis and lipid metabolism were significantly upregulated in the fabT deletion mutant strain. FabT also directly
or indirectly regulated central carbon metabolism genes, including pyruvate hub enzymes and fermentation pathways and viru-
lence genes. Deletion of fabT decreased virulence in a nonhuman primate model of necrotizing fasciitis. In addition, the fabT
deletion strain had significantly decreased survival in human whole blood and during phagocytic interaction with polymorpho-
nuclear leukocytes ex vivo. We conclude that FabT mutant progeny arise during infection, constitute a metabolically distinct
subpopulation, and are less virulent in the experimental models used here.
Streptococcus pyogenes is a Gram-positive bacterium that causesa range of diseases in humans, including pharyngitis, superfi-
cial and deep skin infections, acute rheumatic fever, poststrepto-
coccal glomerulonephritis, bacteremia, and necrotizing fasciitis
(“flesh-eating disease”) (1, 2). Globally, there are over 700million
group A streptococcus (GAS) infections annually (3). It has been
estimated that 9,000 to 11,500 cases of invasive GAS disease occur
each year in the United States, resulting in 1,000 to 1,800 deaths
annually (4; http://www.cdc.gov). Rheumatic fever, necrotizing
fasciitis, and toxic shock syndrome are responsible for the high
morbidity and mortality rates due to GAS infections (5).
Advances in DNA sequencing and related technologies have
facilitated genome-wide dissection of genetic events involved in
colonization (6), immune evasion (7), virulence (8–10), and the
evolution and spread of highly virulent S. pyogenes clones (11–13).
To advance our understanding of S. pyogenes molecular-patho-
genesis events occurring during invasive infection, we performed
whole-genome sequencing of 2,954 isolates recovered fromanon-
human primate model of necrotizing fasciitis. The resulting ge-
nome sequence data stimulated us to construct an isogenic fabT
deletion mutant strain and to compare its global transcriptome
and virulence attributes with those of the wild-type parental
strain.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Escherichia coli strains were
grown in Luria-Bertani (LB) medium at 37°C unless otherwise indicated.
The LBmediumwas supplemented with ampicillin (Fisher Scientific; 150
g/ml) or chloramphenicol (Acros Organics; 20 g/ml) as needed. GAS
was grown in Todd-Hewitt broth (Bacto Todd-Hewitt broth; Becton
Dickinson and Co.) supplemented with 0.2% yeast extract (THY me-
dium). The THY medium was supplemented with chloramphenicol (20
g/ml) as needed. Trypticase soy agar supplementedwith 5% sheep blood
(Becton Dickinson and Co.) was used as required. Polymyxin B was pur-
chased from Sigma. Growth experiments were performed as described
previously (8).
Routine DNA manipulation and analysis. Standard protocols or the
manufacturer’s instructions were used to isolate plasmidDNA for restric-
tion endonuclease, DNA ligase, PCR, and other enzymatic treatments of
DNA. The enzymes were purchased from New England BioLabs, Inc.
(NEB) (Beverly, MA). Plasmid DNA was purified using the Qiaprep Spin
and Qiaquick gel extraction kits (Qiagen). Q5 high-fidelity DNA poly-
merase (NEB) was used as the high-fidelity PCR enzyme. For chromo-
somal-DNA extraction, S. pyogeneswas grown to an optical density (OD)
of 1.0, 800 l of the culture was centrifuged for 1 min at 13,200 rpm
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(high speed), and the pellets were suspended in 800 l water. Bacteria
were lysed with a Fastprep 96 MP instrument (Biomedicals, Santa Ana,
CA) according to the manufacturer’s instructions. The lysates were cen-
trifuged for 2 min at high speed, and 600l of the supernatant was added
to 1.5-ml Eppendorf tubes containing an equal volume of ice-cold isopro-
panol. After incubation at 20°C for 2 h, the tubes were centrifuged at
high speed for 30min, the supernatant was discarded, and the pellets were
washed with 70% ice-cold ethanol. After a final high-speed centrifugation
for 30 min, the supernatant was decanted, and the pellets were dried by
incubating the inverted tubes for30min. The pellets were suspended in
50 to 100 l of water, and 1 l of this chromosomal DNA was used for
subsequent PCRs.
RoutineDNA sequencingwas performedwith a 3730 xl DNA analyzer
(Applied Biosystems) and a BigDye Terminator v3.1 Cycle Sequencing kit
(Life Technologies). Oligonucleotides were purchased from Sigma-Al-
drich. The sequences of relevant primers used in PCR-based cloning are
shown in Table S1 in the supplemental material. The genomes of all final
cloneswere sequenced for verification and to rule out spuriousmutations.
Experimental animal infection. A nonhuman primate model of ne-
crotizing fasciitis was used (14). Four adult cynomolgus macaques
(Macaca fascicularis; Charles River BRF) were inoculated intramuscularly
in the anterior thigh to a uniform depth with 1  108 CFU/kg of body
weight of the S. pyogenes emm1 strain MGAS2221. Strain MGAS2221 was
used because it has a wild-type allele (i.e., the most common allele) for all
major transcriptional regulators, it is genetically representative of con-
temporary epidemic serotypeM1 strains, and it has been used extensively
in animal experiments (12). The animals were observed continuously,
sacrificed at 24 h postinoculation, and necropsied. At necropsy, the quad-
riceps muscle was removed en bloc, serially sectioned in 0.5-cm slices, and
visually inspected. Biopsy specimens of grossly purulent tissue (0.5 g
each) were collected from the inoculation site, 1 cm from the caudal
margin, and 1 cm from the cephalic margin. Each muscle sample was
homogenized (Omni International), serially diluted in sterile phosphate-
buffered saline (PBS), and plated in quadruplicate on Trypticase soy agar
supplemented with 5% sheep blood (Becton Dickinson and Company).
Following incubation at 37°C with 5% CO2 for 18 h, colonies were
counted. Colonies (n  768) from each animal were saved for whole-
genome sequencing. To avoid introducing bias due to colony phenotype,
every colony was taken from plates prepared from the dilution that pro-
duced approximately 100 to 200 colonies/plate. The study protocol (AUP-
0521-0027) was approved by the Institutional Animal Care andUse Com-
mittee, Houston Methodist Research Institute.
For analysis of the virulence of the fabT deletion mutant strain, two
adult cynomolgus macaques (M. fascicularis; Charles River BRF) were
used, as previously described (12, 14). Each animal was anesthetized and
inoculated intramuscularly in the anterior thighs. The right quadriceps
muscle was inoculated at a marked site with wild-type strain MGAS2221,
and the left quadriceps muscle was inoculated at a marked site with the
fabT-deficient strain MGAS2221fabT. The animals were observed con-
tinuously, sacrificed at 24 h postinoculation, and necropsied. At necropsy,
the quadriceps muscle was removed en bloc, serially sectioned, and visu-
ally inspected. Tissues from the inoculation site and cephalic margin (1
cm from the distal margin) were collected for enumeration of CFU and
microscopic examination using standard methods. The study protocol
was approved by the Houston Methodist Research Institute (protocol
number AUP-0115-0004).
Whole-genome sequencing and polymorphism analysis. Sequenc-
ing libraries were prepared from 768 colonies collected from the infected
muscle of each animal (3,072 colonies in total) as described previously
(12, 15). Genome sequence data were obtained with a HiSeq 2000 instru-
ment (Illumina, Inc.) according to the manufacturer’s instructions. The
sequence reads were corrected using Musket (16) and mapped to the
reference serotype M1 strain MGAS5005 (GenBank accession number
CP000017) using SMALT (available at http://www.sanger.ac.uk/resources
/software/smalt/). Single nucleotide polymorphisms (SNPs) and insertions
and deletions (indels) were identified using FreeBayes (available at http:
//www.github.com/ekg/Freebayes/) as described previously (17). The nature
of theSNPs (coding/noncoding, synonymous/nonsynonymous, etc.)wasde-
termined using SNPfx.pl (a PERL script developed in house).
Construction of an isogenic fabT deletion mutant strain. To con-
struct a fabT deletion mutant from wild-type emm1 strain MGAS2221
(MGAS2221fabT), we replaced the entire coding region of the fabT gene
with the coding region of the cat gene (encoding chloramphenicol acetyl-
transferase) from plasmid pDC123. Thus, the fabT promoter drives the
expression of the cat gene in the final construction. This strategy allowed
the use of positive selection for the gene replacement through a double-
crossover recombination event by plating target cells on chlorampheni-
col. In addition, we avoided complications, such as interruption of a pu-
tative operon or creation of polar effects on downstream genes that could
occur by introduction of a plasmid backbone into this DNA region via a
single-crossover event. The gene fabH, which is located immediately
downstream from fabT, is typically essential (18). All relevant primer
DNA sequences, along with a depiction of the steps in mutant strain
construction, are shown in Fig. S1 in the supplemental material.
Primers JE66 and JE67were used to amplify a 1,964-bpDNA fragment
containing the 435-bp fabT gene and 760 bp upstream (5= to fabT) and
769 bp downstream (3= to fabT) from MGAS2221 chromosomal DNA.
The JE66 DNA sequence is located internal to the phaB gene upstream
from fabT (see Fig. S1 in the supplemental material). Similarly, the JE67
DNA sequence is located internal to the fabH gene downstream from
fabT. We designed the primers internal to these genes to avoid amplifying
the full-length version of either phaB or fabH, thus minimizing the likeli-
hood of cloning complications due to toxicity.
The 1,964-bp PCR product was used as a template for construction of
the fabT deletion mutant using combinatorial PCR (19). Briefly, the re-
gion 5= to fabT was amplified with primers JE66 and JE69; to amplify the
region 3= to fabT, we used primers JE67 and JE63. The 5= ends of primers
JE69 and JE63 contain 15 bp that are complementary to the 5= and 3= ends
of the cat gene, respectively. The 651-bp cat gene was amplified from
pDC123with primers JE68 and JE62 as forward (FWD) and reverse (REV)
primers, respectively. These primers contain 15 bp at their 5= ends com-
plementary to the immediate DNA sequences located upstream and
downstream of fabT. Thus, wemade three contiguous PCR fragments: (i)
upstream of fabT, (ii) the cat gene, and (iii) downstream of fabT (see Fig.
S1 in the supplemental material). Combinatorial PCR was performed in
two sequential steps. First, the upstream fabT PCR product and the cat
gene DNA were combined using primers JE66 and JE62. Second, the
downstream fabTPCR fragmentwas used as a template, together with this
PCR fragment, to generate a new 2,180-bp PCR fragment containing the
cat gene (instead of fabT plus the sequences upstream and downstream of
fabT), using the external JE66 and JE67 primers. Finally, the fragment was
reamplified using FWD primer JE70, which has the same DNA sequence
as JE66 and a BamHI restriction site, and REV primer JE67. This consti-
tuted the PCR fragment used for allelic exchange.
Upon digestion with BamHI, the target PCR fragment was cloned into
pBluescript (pBSII KS) digested with BamHI and SmaI and subsequently
excised as a BamHI-HindIII fragment and cloned into the GAS suicide
vector pBBL740, which had been digestedwith BamHI andHindIII.E. coli
JM109 was used for all cloning experiments. The final recombinant plas-
mid was extracted from 100 ml of JM109 cells, digested with BamHI,
extracted from a gel, column purified, and electroporated into strain
MGAS2221. Transconjugants and controls were inoculated onto THY
plates containing chloramphenicol. PCR analysis of transconjugants con-
firmed that the fabT gene had been successfully replaced.
Two sets of primers were used to confirm that the fabT gene had been
successfully replaced with cat. Primers JE1 and JE5 generate a PCR prod-
uct that extends 143 bp upstream and 100 bp downstream of fabT. When
we used wild-type MGAS2221 chromosomal DNA as a template, we gen-
erated the expected 678-bp PCR fragment. In contrast, the size of the PCR
fragment amplified from both candidate mutant strains was 894 bp, as
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expected. Primers JE12 and JE9 were used to verify that the DNA region
flanking the deleted fabT genewas intact.DNA sequencing confirmed that
both clones contained the correct chromosomal replacement. Further,
whole-genome sequencing of both mutant strains (MGAS2221fabT-1
and MGAS2221fabT-2) further confirmed that (i) the replacement was
in the appropriate chromosomal location within the Fab gene cluster and
the DNA sequence was correct and (ii) there were no DNA sequences
corresponding to the plasmid backbone in the chromosome. We arbi-
trarily chose strain MGAS2221fabT-1 for further analysis, which for
simplicity we designated strain MGAS2221fabT.
Genome-wide transcriptome-sequencing (RNA-seq) analysis. The
wild-type M1 strain MGAS2221 and the isogenic fabT deletion mutant
MGAS2221fabT were grown overnight in 10 ml of THY medium with
5% CO2 at 35°C or 40°C. Aliquots (0.6 ml) from overnight cultures were
used to inoculate 30 ml of prewarmed THY medium in 50-ml conical
tubes (1:50 dilution) at 35°C and 40°C. Each strainwas grown in triplicate,
and samples were collected when the absorbance at 600 nm reached an
OD of 1.0 and exactly 2 h after the OD reached 1.4, corresponding to the
mid-exponential and stationary phases of growth, respectively. Bacteria
from the stationary phase or mid-exponential phase, 1 and 2 ml, respec-
tively, were added to RNAprotect Bacteria Reagent (Qiagen) and centri-
fuged at 4,000 rpm for 10 min. The supernatant was discarded, and the
bacterial pellet was frozen in liquid nitrogen and stored at80°C.
The frozen cell pellets were thawed on ice and suspended in 100 l of
RNase-free Tris-EDTA (TE) buffer, pH 7.0 (Ambion), for RNA extrac-
tion. The bacteria were added to 2-ml tubes containing lysismatrix B (MP
Biomedicals) and lysed using a FastPrep-96 instrument (MP Biomedi-
cals). The RNA was extracted with an RNeasy minikit (Qiagen) following
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FIG 1 Location of nonsynonymous substitutions within FabT. (A) Secondary-structure prediction for FabT derived from Jpred. Nonsynonymous substitutions
are represented in black (mutations identified in isolates cultured from nonhuman primates) and red (mutations identified in isolates cultured from humans).
Stop codons are represented by green arrowheads (mutations identified in isolates cultured fromnonhumanprimates). The residues in blue are conserved among
members of the MarR superfamily of proteins. (B) Helical-wheel representation of the FabT amphipathic alpha helix 5 (5). The amino acid sequence, with the
mutated residues in red, is shown at the bottom; polar and hydrophobic residues are represented by yellow circles and blue squares, respectively. The resulting
nonsynonymous substitutions are shown in red, and the arrows denote the corresponding changes. Primates, nonhuman primates; Humans, host from which
the respective mutated GAS strain was isolated.
Eraso et al.
3270 iai.asm.org December 2016 Volume 84 Number 12Infection and Immunity
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
the manufacturer’s instructions. The extracted RNA was subjected to
three consecutive DNase treatments with Turbo DNA-free (Ambion),
and the quality of the total RNA was evaluated with an Agilent 2100
Bioanalyzer and 2100 Expert software and with RNANano chips (Agilent
Technologies). For the subsequent steps, we used the ScriptSeq Complete
kit for bacteria (Epicentre), and rRNAwas depleted with Ribo-Zeromag-
netic beads. The quality of the rRNA-depleted RNA was evaluated with
RNA Pico chips (Agilent Technologies) and an Agilent 2100 Bioanalyzer.
The cDNA libraries were prepared with indexed reverse primers from the
ScriptSeq Index PCRprimer kit (Epicentre) and purifiedwith AMPureXP
beads (Agencourt, Beckman Coulter, Inc.). The quality of the cDNA li-
braries was evaluated with DNA high-sensitivity chips (Agilent Technol-
ogies) and an Agilent 2100 Bioanalyzer. For each sample, the cDNA li-
brary concentration was measured fluorometrically with Qubit dsDNA
HS assay kits (Invitrogen). The cDNA libraries were diluted, pooled, and
analyzed with an Illumina HiSeq 2500 instrument.
We obtained an average of 107 reads/sample for the 24 samples (wild-
type and fabT mutant strains grown at 35°C and 40°C, with two time
points recorded at the mid-exponential and stationary phases and each
sample grown in triplicate). Adapter contamination was removed from
the FASTQ sequence files using Trimmomatic (20), and theRNA-seq data
were analyzedwithCLCBioCLCGenomicsWorkbench version 7.0 (Qia-
gen). Reads were mapped to the genome of the emm1 reference strain
MGAS5005, excluding rRNA and tRNA genes. Gene expression values
from each strain and set of conditions were compared. The Baggerly test
and Bonferroni correction were used to test for differential transcript
expression. We considered a gene to be differentially expressed when the
change in the transcript level differed by at least 1.5-fold between strains
and the P value was less than 0.05.
Spot dilution assays. The wild type, the fabT deletion mutant,
MGAS1253, and MGAS25770 were grown overnight to stationary phase,
diluted 1:50 in the morning, and grown to an OD of 0.6 to 0.8 in THY
medium. Serial dilutions were made in fresh THY broth, and 2.5 l of
each diluted solution was inoculated onto the surfaces of THY plates
containing the appropriate polymyxin B concentration. The plates were
incubated for approximately 24 h and scored. The experiments were re-
peated in triplicate.
Survival of S. pyogenes strains in whole human blood. Bactericidal
assays with whole human blood were performed using a standard phago-
cytosis method with minor modifications (21). The wild-type M1 strain
MGAS2221 and the isogenic fabT deletion mutant were grown to early
mid-exponential phase in THY medium with 5% CO2 at 37°C (OD600,
0.150 to 0.220). The bacteria were diluted to 104 in sterile saline. A
total volume containing 500 l blood and 50 l diluted bacteria (103
bacteria/ml blood) was dispensed into a 1.5-ml Eppendorf tube. Heparin
was used at 5 U/ml. All studies with human blood and polymorphonu-
clear leukocytes (PMNs) were performed in accordance with a protocol
(01-I-N055) approved by the Institutional Review Board forHuman Sub-
jects, National Institute of Allergy and Infectious Diseases, National Insti-
tutes of Health. All subjects gave written informed consent prior to par-
ticipation in the study.
GAS survival following exposure to purified PMNs. Human PMNs
were purified from heparinized blood of healthy donors using a standard
method (22). The wild-type strain MGAS2221 and the isogenic fabT de-
letion mutant were grown to early mid-exponential phase in THY me-
dium with 5% CO2 at 37°C (OD600,0.150 to 0.220). A total volume of
600 l containing 106 PMNs, 106 bacteria, and 10% autologous serum in
HEPES-buffered RPMI 1640mediumwas dispensed into a 1.5-ml Eppen-
dorf tube. The assay mixtures were rotated gently at 37°C for 1 h or 3 h, at
which time saponin (0.1% final concentration) was added to each assay
mixture, and the tubes were placed on ice for 15 min. An aliquot of each
tube was diluted appropriately and plated on THY agar plates, and colo-
nies were counted the next day. The percent GAS survival was determined
by comparing CFU from assays with PMNs to CFU from assays without
PMNs. Data at each time point were analyzed with a paired t test (Prism 6
for Windows; GraphPad Prism; GraphPad Software Inc.).
Accession number(s). The sequence data have been deposited in the
National Center for Biotechnology Information (NCBI) Sequence Read
Archive (http://www.ncbi.nlm.nih.gov/sra) under accession number
SRP087644 and in the NCBI Gene Expression Omnibus (GEO) under
accession number GSE86854.
RESULTS
Identification of acquired polymorphisms in serotype M1 strain
MGAS2221 during host infection. With the goal of analyzing in-
trahost genomic variation during experimental necrotizing fascii-
tis infection, four animals were inoculated intramuscularly with
the serotypeM1 strainMGAS2221. This infectionmodel has been
used extensively and recapitulates human disease (14, 23, 24).
Strain MGAS2221 was used because its genome has been se-
quenced to high quality, it has been used inmany previous studies
of necrotizing fasciitis, and it lacks mutations in major regulatory
genes (25–28).
Twenty-four hours after infection, we recovered 768 colonies
per animal and performed whole-genome sequencing. High-
quality sequencing data were obtained for 698, 760, 743, and 753
strains from each animal, resulting in whole-genome sequence
data for 2,954 strains. Analysis of the sequence data found that
approximately 20% of these strains had one single nucleotide
change, and only a small percentage (47 of 2,954 strains [1.6%])
had two or more changes. There was a strongly nonrandom
genomic distribution of polymorphisms in that 50% were lo-
cated in fabT (Spy_1495), a 435-nucleotide gene encoding a tran-
scriptional repressor of fatty acid (FA) synthesis. All the identified
nonsynonymous FabT amino acid substitutions are shown in
Δ
Δ
35°C
40°C
A
B
FIG 2 Growth curves. The wild-type strainMGAS2221 and the FabT deletion
strain MGAS2221fabT were grown at 35°C (A) and 40°C (B) in THY
medium.
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Fig. 1A. Sixty of 66 SNPs (91%)were nonsynonymous, and 6 were
synonymous (9%). In addition, among the 36 indels, 4 were in
frame (11%) and 32 (89%)would result in a frame-shiftedmutant
FabT protein. Thirty of the 144 amino acids encompassing FabT
(21%) had amino acid replacements, of which 20 were single, 6
were double (where either of 2 amino acids replaced the wild-type
amino acid residue), and 4 were triple replacements (Fig. 1A and
B). Thus, we identified a total of 44 amino acid replacements at 30
positions in the FabT protein. Several of thesemutations occurred
more than once in strains isolated from different nonhuman pri-
mates, likely indicating that the polymorphisms arose indepen-
dently. In addition to amino acid replacements, other mutations
gave rise to 13 nonsense codons in fabT. Their distribution was
widespread across the gene (Fig. 1A, green triangles); for the 145
codons, the closest to the fabT 5= end occurred at codon 2 and at
the 3= end at codon 138.
We recently sequenced the genomes of 3,615 pandemic sero-
typeM1 strains isolated from human patients with invasive infec-
tions or pharyngitis (12). The fabT gene ranked 11th among
genes containing polymorphisms in these 3,615 strains. After
grouping the polymorphisms as a nonredundant set, we found
three insertions, one deletion, and five nonsynonymous SNPs
in the fabT coding sequence (Fig. 1A, red arrows and altered
amino acid residues). In addition, two SNPs were found imme-
diately upstream of fabT at positions 47 and 48, located
between the putative 35 and 10 promoter regions. Similar
upstream SNPs were found in the invasive GAS strains isolated
from nonhuman primates in this study (data not shown). The
phylogenetic distribution of the strains isolated from human
patients with fabT polymorphisms indicates that most of the
changes likely originated independently (see Fig. S2 in the sup-
plemental material).
Several of the altered amino acid residues identified in the pres-
ent study are highly conserved among the MarR superfamily of
transcriptional regulators (Fig. 1A, blue residues). The FabT
amino acid changes are primarily clustered in -helices 2 through
5. Of note, the variant amino acids do not appear to be randomly
distributed. For example, the polymorphisms mapping to -helix
5 cluster primarily on the hydrophobic face of the amphipathic
helix (Fig. 1B). This region could either be involved in dimeriza-
tion (29) or provide a hydrophobic pocket for an effector mole-
cule involved in allosteric regulation of FabT.
Growth characteristics of a fabT deletion mutant strain.
To begin to determine the role of FabT in S. pyogenes pathogene-
sis, we constructed the isogenic fabT deletion mutant strain
MGAS2221fabT. In this mutant, the entire fabT gene is replaced
with the coding sequence of the cat gene, encoding chloramphen-
icol acetyltransferase, resulting in the intact fabT promoter driv-
ing transcription of cat and downstream genes.
We tested the hypothesis that the fabTmutant strain differed in
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FIG 3 Area-proportional Venn diagrams representing differentially expressed genes. (A to D) Genes differentially expressed at 35°C and 40°C. Common genes
differentially expressed at both growth temperatures are also depicted. (A) Genes upregulated during mid-exponential phase. (B) Genes upregulated during
stationary phase. (C) Genes downregulated during mid-exponential phase. (D) Genes downregulated during stationary phase. (E to H) Genes differentially
expressed during mid-exponential and stationary phases. Common genes differentially expressed during both phases of growth are also depicted (E) Genes
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growth characteristics from the wild-type parental organism. Two
different temperatures were used for this analysis, selected to rep-
resent differences in affected anatomical sites: 35°C for pharyngi-
tis (30) and 40°C for serious invasive infections. Both strains grew
to an OD of 1.5 at both temperatures (Fig. 2). However, the fabT
deletionmutant strain consistently required a longer time to reach
the mid-exponential phase (OD  0.5) at 40°C. Once this OD
value was reached, the doubling times were similar for both
strains, as calculated from the corresponding logarithmic graphs
(data not shown). A similar growth pattern was observed at 37°C
(data not shown). Thus, although the growth rates of wild-type
MGAS2221 and the isogenic fabT deletion mutant were similar
under the experimental conditions, the fabT mutant strain had a
prolonged lag phase early in growth compared to the wild-type
parental strain.
RNA-seq analysis to identify differentially expressed genes.
We next performed RNA-seq analysis to identify genes whose ex-
pression was directly or indirectly regulated by FabT. The wild-
type strain (MGAS2221) and the fabT deletion mutant strain
(MGAS2221fabT) were grown at 35°C and 40°C, and samples
acquired at the mid-exponential (OD  1.0) and stationary (2 h
after an OD of 1.4 was reached) growth phases were analyzed.
Depending on the growth temperature and phase, between 3.7
and 28.5% of the 1,841 S. pyogenes genes (excluding rRNA and
tRNA genes) were differentially expressed in the mutant strain.
Notably, the number of differentially expressed genes was greater
during stationary phase (see Table S1 in the supplemental mate-
rial). Genes involved in transport, translation, nucleotide trans-
port and metabolism, and central metabolism were primarily af-
fected, although most functional categories were represented.
Based on the large number of differentially expressed genes, a
substantial proportion are likely to be regulated indirectly rather
than directly by FabT. A comprehensive list of the genes differen-
tially expressed under each condition is presented inTables S2 and
S3 in the supplemental material.
The genes differentially expressed according to either growth
temperature or growth phase, including genes differentially regu-
lated in more than one category, are shown in Fig. 3. The genes
were categorized based on their differential expression at one or
both growth phase time points and/or their differential expression
at one or both growth temperatures. We hypothesized that the
genes directly regulated by FabT would be differentially expressed
under all the conditions tested. Several genes meeting these crite-
ria are discussed below.
Twenty-seven genes were upregulated at both 35°C and 40°C
duringmid-exponential phase in the FabTmutant strain, and this
B
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FIG 4 Regulation of fab genes by FabT. (A) The Fab cluster of GAS, showing the locations of three putative FabT-binding DNA sequences (asterisks) located in
front of phaB, fabT, and fabK. fabT is depicted in red. (B) Fold expression of each gene at both temperatures and phases of growth. The values in red indicate either
that the differential fold expression was below the allotted 1.5 or that the P value was excluded after applying the Bonferroni correction. (C) Figure representing
the regulatory regions of phaB, fabT, and fabK, with putative promoter sequences and FabT-bindingDNA sequences indicated.Nucleotide residuesmatching the
promoter sequence and FabT site are indicated in blue and red, respectively.
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number increased to 57 during stationary phase (Fig. 3A and B).
Conversely, 10 and 83 genes were downregulated at both temper-
atures during the mid-exponential and stationary phases, respec-
tively (Fig. 3C and D). Thus, 8 to 18% of the differentially ex-
pressed genes were shared at both growth temperatures, whereas a
larger group of genes were differentially expressed at only one
growth temperature.
Thirty-one and 16 genes were commonly upregulated at 35°C
and 40°C, respectively, in both phases of growth (Fig. 3E and G).
Conversely, 35 genes were downregulated during both phases of
growth at 35°C, but only 6 at 40°C (Fig. 3F andH). Thus, 8 to 10%
of the genes were commonly shared between themid-exponential
and stationary phases of growth, apart from downregulated genes
in the fabT deletion mutant at 40°C, in which only 1.6% of the
geneswere shared. Thus, a larger groupof geneswere differentially
expressed in only one of the two growth phases.
Genes differentially expressed under all conditions tested:
FA synthesis genes. Consistent with the function of FabT as a
transcriptional repressor of FA synthesis genes in other bacterial
species (31–33), all genes in the fatty acid biosynthesis (Fab) gene
cluster were upregulated in the isogenic fabT deletion strain under
all conditions tested. The Fab cluster in strainMGAS2221 consists
of 13 genes (Fig. 4A). The fold differences were more pronounced
in the stationary phase of growth at both 35°C and 40°C (Fig. 4B).
Based on the magnitude of the changes, and assuming no major
differences inmRNAhalf-life, our data suggest that the Fab cluster
in S. pyogenes is divided into three distinct transcriptional units.
First, there is a putativemonogenic transcript of Spy_1496 (phaB).
A second putative transcript encompasses Spy_1495 (fabT),
Spy_1494 (fabH), and Spy_1493 (acpP), consistent with data from
Streptococcus pneumoniae (33). A third putative long transcript
encompasses Spy_1492 (fabK) at the 5= end, extending to the 3=
end of Spy_1484 (accA). This transcriptional organization is con-
sistent with the presence of three putative FabT-binding sites lo-
cated upstream of phaB, fabT, and fabK (Fig. 4A, asterisks). Based
on homology with a consensus FabT operator site, their locations
in the respective genes in relation to promoter and translation
initiation codons are shown in Fig. 4C. These data are consistent
with our hypothesis that genes and/or operons directly regulated
by FabT are upregulated in the fabT deletionmutant under all the
conditions tested.
Additional genes or operons upregulated under all the con-
ditions tested are listed in Table 1. Matches to the FabT DNA-
binding consensus sequence were detected in their upstream
regulatory regions, suggesting that FabT directly regulates the
expression of these genes (data not shown).
Selected genes that were downregulated in the isogenic fabT
deletion mutant compared to the wild type under at least two of
the conditions studied are involved in sugar utilization and fer-
mentation pathways (Table 2). No putative FabT-binding DNA
sequences were found in the regulatory regions of these genes,
suggesting that FabT indirectly regulates their expression.
Differential expression of genes related to metabolism. The
RNA-seq analysis identified differential expression of many genes
related to metabolism, including genes encoding enzymes in-
volved in the pyruvate hub, fermentation pathways, and entry of
carbon sources into the glycolytic pathway (Table 3). Taken to-
gether, carbon flow around the pyruvate hub and fermentation of
carbon sources, including the pathways and end products, may be
different in the fabT deletion mutant than in the wild type.
Genes encoding enzymes involved in use of alternative carbon
sources, other than glucose, were also differentially expressed. For
example, genes encoding enzymes favoring the entrance of glu-
cose-1-phosphate, mannose-6-phosphate, and fructose-1-phos-
phate into upper glycolysis were upregulated in the fabT deletion
mutant compared to the wild type (Table 3). In contrast, other
pathways funneling carbon into glycolysis, such as glycerol trans-
port and degradation and citrate andmalate utilization, which are
abundant in host tissues, andmaltose transport and its conversion
into glucose, were downregulated in the fabT deletion mutant
TABLE 1 Genes upregulated in the fabT mutant, compared to the wild
type under all conditions tested
Locus taga Gene
Fold changeb
35°C 40°C
ME Stat ME Stat
Spy_1828 39.5 36.7 30.3 25.5
Spy_0879 dgk 3.5 9.7 3.2 5.5
Spy_0880 hlyIII 5.3 12.5 4.4 4.9
Spy_0881 6.4 7.5 5.2 3.1
Spy_0385 5.4 2.5 5.0 2.1
Spy_1650 degV 1.8 2.8 1.9 1.7
a Spy_1828 encodes a membrane protein used as a phage receptor in Lactococcus lactis,
Spy_0879 encodes a putative diacyl glycerol kinase, Spy_0880 encodes a hemolysin
III-related protein, Spy_0881 encodes a transcriptional regulator of the MerR family,
Spy_0385 encodes acute rheumatic fever myosin cross-reactive protein, and Spy_1650
encodes an uncharacterized protein containing a bound fatty acid molecule.
b ME, mid-exponential growth phase; Stat, stationary growth phase.
TABLE 2 Genes downregulated in the fabT mutant compared to the
wild type under the tested conditions
Locus taga Gene
Fold change relative to wild typeb
35°C 40°C
ME SP ME SP
Spy_1415 sdaD2 2.1  3.3 2.8
Spy_0039 adh2 4.3 3.5  
Spy_0040 adhA 3.5 4.9  2.9
Spy_1681 dexB 2.3 1.7  1.8
Spy_1783 dexS 3.7 6.6  3.2
Spy_1395 lacD.1 3.3 4.7  4.0
Spy_1396 lacC.1 5.9 4.7  4.4
Spy_1397 lacB.1 4.8 4.6  3.6
Spy_1398 lacA.1 4.3 4.5  3.3
Spy_1632 lacG  4.3  5.4
Spy_1635 lacD.2  3.5  
Spy_1636 lacC.2  3.3  2.8
Spy_1637 lacB.2  3.0 2.7 3.3
Spy_1638 lacA.2  3.2 2.6 4.1
Spy_0094 ackA  1.6  2.7
Spy_0851 pta  1.6  1.6
a Spy_0039 and Spy_0040 encode a bifunctional acetaldehyde/alcohol dehydrogenase
and an alcohol dehydrogenase, respectively; Spy_ 1681 encodes glucan
1,6-alpha-glucosidase; Spy_ 1783 encodes a putative alpha amylase/glycosidase;
Spy_1395, Spy_1396, Spy_1397, and Spy_1398 encode enzymes of the tagatose pathway
cluster 1; Spy_1632, Spy_1635, Spy_1636, Spy_1637, and Spy_1638 encode enzymes of
the tagatose pathway cluster 2; Spy_0094 encodes acetate kinase. Spy_0851 encodes
phosphotransacetylase. The shaded rows indicate genes in the same operon.
b ME, mid-exponential growth phase; SP, stationary growth phase., the gene does not
satisfy the P value (including the Bonferroni correction) and/or fold requirement.
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during the stationary phase of growth at 35°C. These results sug-
gest that entry of carbon sources other than glucose into the Em-
bden-Meyerhof-Parnas (glycolysis) pathway may occur differ-
ently in the fabT deletion mutant than in the wild type.
The two gene clusters encoding proteins and enzymes involved
in lactose and galactose transport and degradation, the tagatose
pathway, were also downregulated in the FabT mutant at both
temperatures during the stationary phase (Table 2). Cluster I, or
Lac.1, is specific for galactose (34, 35). It contains genes extending
from Spy_1395 to Spy_1402. The genes present in cluster II, or
Lac.2, are specific for lactose (34, 35). They extend from Spy_1632
to Spy_1639. Interestingly, LacD.1 acts as a transcriptional regu-
lator of virulence genes (34).
Differential expression of genes related to virulence. Differ-
entially expressed virulence genes are shown in Table 4. Spy_1106
(grab) and Spy_1720 (mga) were significantly upregulated during
the mid-exponential and stationary phases, respectively, at both
growth temperatures. These genes encode GRAB, a surface-an-
TABLE 3 Carbon metabolism genes differentially expressed between the isogenic fabT deletion mutant and the wild-type strain MGAS2221 grown
at 35°C
Locus tag Gene Fold changea Growth phaseb Function
Pyruvate hub enzymes
M5005_Spy0751 acoA 2.5 ME Pyruvate dehydrogenase E1 component, alpha subunit
M5005_Spy0752 acoB 2.5 ME Pyruvate dehydrogenase E1 component, beta subunit
M5005_Spy0753 acoC 2.4 ME Pyruvate dehydrogenase, dihydrolipoamide acyltransferase
(E2) component
M5005_Spy0755 acoL 2.4 ME Pyruvate dehydrogenase, dihydrolipoamide dehydrogenase
(E3) component
M5005_Spy1569 pfl 1.8 ME Pyruvate formate lyase
M5005_Spy1841 sdhB 6.3 ME Serine dehydratase beta chain
M5005_Spy1842 sdhA 6.0 ME Serine dehydratase alpha chain
Genes involved in fermentation pathways
M5005_Spy0873 ldh 2.3 SP L-Lactate dehydrogenase
M5005_Spy0039 adh2 4.3 ME Acetaldehyde dehydrogenase
M5005_Spy0040 adhA 3.5 ME Alcohol dehydrogenase
M5005_Spy0039 adh2 3.5 SP Acetaldehyde dehydrogenase
M5005_Spy0040 adhA 4.9 SP Alcohol dehydrogenase
M5005_Spy0094 ackA 1.6 SP Acetate kinase
M5005_Spy0851 pta 1.6 SP Phosphotransacetylase
Upregulated genes involved in entry of carbon
sources into the Embden-Meyerhof-
Parnas (glycolysis) pathway
M5005_Spy0661 fruB 3.3 SP L-Phosphofructokinase
M5005_Spy0938 pgmA 1.6 SP Phosphoglucomutase
M5005_Spy1538 pmi 1.6 ME Mannose-6-phosphate isomerase
Downregulated genes involved in entry of
carbon sources into the Embden-
Meyerhof-Parnas (glycolysis) pathway
M5005_Spy0903 oadB 2.5 SP Oxaloacetate decarboxylase beta subunit
M5005_Spy0905 citD 1.9 SP Citrate lyase subunit gamma
M5005_Spy0906 citE 1.9 SP Citrate lyase subunit beta/citryl-CoA lyase subunit
M5005_Spy0907 citF 2.0 SP Citrate lyase subunit alpha/citrate CoA-transferase
M5005_Spy0908 citX 2.4 SP Citrate lyase activation subunit
M5005_Spy1062 malA 2.1 SP Maltodextrose utilization protein
M5005_Spy1063 malD 2.1 SP ABC transporter transmembrane subunit
M5005_Spy1064 malC 2.0 SP Maltose/maltodextrin transporter membrane protein
M5005_Spy1067 malX 2.0 SP Maltose/maltodextrin transporter subunit
M5005_Spy0832 maeP 11.3 SP Putative malate transporter
M5005_Spy0833 maeE 10.0 SP Malic enzyme
M5005_Spy1379 glpF 4.4 SP Glycerol uptake facilitator
M5005_Spy1380 glpO 4.6 SP Glycerol-3-phosphate dehydrogenase
M5005_Spy1381 glpK 5.5 SP Glycerol kinase
M5005_Spy1542 scrA 2.4 SP Sucrose-specific transporter PTS system subunit II
M5005_Spy1543 scrB 2.4 SP Glycosyl hydrolase involved in sucrose utilization
M5005_Spy1544 scrR 2.4 SP Putative transcriptional regulator involved in sucrose
utilization
a Fold change in the fabT mutant relative to the wild type.
b ME, mid-exponential growth phase; SP, stationary growth phase.
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chored protein that binds 2-macroglobulin, a major protease
inhibitor present in human plasma (36), and Mga, a critical pos-
itive transcriptional regulator of virulence genes found in all GAS
strains. Conversely, the gene encoding the two-component system
histidine kinase CovS, Spy_0283 (covS), and the sic gene
(Spy_1718), which encodes the streptococcal inhibitor of comple-
ment (SIC), were downregulated in the stationary and mid-expo-
nential phases, respectively, at both growth temperatures.
The other genes in Table 4 were differentially regulated under
only one of the assay conditions tested. The streptolysin S biosyn-
thesis genes were upregulated in the fabT deletion mutant during
the stationary growth phase at 40°C. Spy_0385, which encodes a
67-kDa myosin-cross-reactive antigen involved in fatty acid me-
tabolism (37, 38), and Spy_0880 (hlyIII), encoding a hemolysin
III-like protein that in Bacillus cereus is involved in erythrocyte
lysis (39), were upregulated under all conditions tested. We iden-
tified putative FabT-binding sequences immediately upstream of
Spy_0385 and upstream of Spy_0881 (see Fig. S3A in the supple-
mental material). In addition, Spy_1415 (sdaD2), which encodes
streptodornase, was downregulated under three of the conditions
tested, but not during stationary phase at 35°C.
Other notable differentially expressed genes. Pyrimidine and
purine synthesis genes were also differentially expressed. Genes
involved in the de novo pyrimidine synthesis were downregulated
in the fabT mutant strain during the mid-exponential phase of
growth and upregulated in the stationary phase, preferentially at
35°C (see Fig. S4 in the supplemental material). Genes in the pu-
rine synthesis pathway were downregulated during the stationary
phase in the fabT deletion mutant compared to the wild type (see
Fig. S5 in the supplemental material). Pyrimidine and purine
bases and nucleosides are either unavailable or at very low con-
centrations as exogenous nutrients (40, 41), especially in human
plasma, where S. pyogenes increases the de novo synthesis of both
pyrimidines and purines (42).
Spy_0687 (mvaS1) and Spy_0686 (mvaA), which encode
HMG-coenzyme A (CoA) synthase and HMG-CoA reductase,
two enzymes that control entry points to themevalonate pathway,
were upregulated in the fabT deletionmutant by	1.7-fold during
the stationary phase. Themevalonate pathway is required tomake
undecaprenyl pyrophosphate and lipid II (43). The consequence
of this upregulation in the fabT deletion mutant strain might be
increased production of lipid II, potentially leading to (i) in-
TABLE 4 Differentially expressed virulence genes in the isogenic fabT deletion mutant compared to wild-type MGAS2221
Locus tag Gene Gene product
Fold changea
35°C 40°C
Upregulated Downregulated Upregulated Downregulated
ME SP ME SP ME SP ME SP
Spy_0205 fasC Histidine kinase; streptokinase regulator 1.7
Spy_0206 fasA Response regulator 1.6
Spy_0385 Myosin cross-reactive antigen 5.4 2.5 5.0 2.1
Spy_0565 sagD Streptolysin S biosynthesis scaffold/docking protein 1.8
Spy_0566 sagE Streptolysin S biosynthesis protease associated 1.8
Spy_0567 sagF Streptolysin S biosynthesis; SagF protein 1.7
Spy_0568 sagG Streptolysin S biosynthesis; ATP-binding export protein 1.7
Spy_0571 Predicted extracellular nuclease 1.8
Spy_0880 hlyIII Hemolysin III homolog, which might cause erythrocyte lysis 5.3 12.5 4.4 4.9
Spy_1106 grab Surface protein that binds the plasma proteinase inhibitor
2-macroglobulin
1.9 2.9
Spy_1333 liaS Histidine kinase 1.6
Spy_1599 pgk Phosphoglycerate kinase (PGK); binds plasminogen and also
blocks assembly of MAC
1.6
Spy_1720 mga Transcriptional regulator of virulence genes 1.5 1.5
Spy_1737 ropB Regulator of protease B (RopB) 1.7
Spy_0139 nga Nicotine adenine dinucleotide glycohydrolase (NADase) 3.2
Spy_0140 ifs Protein immunity factor for Nga 3.2
Spy_0141 slo Streptolysin (SLO), a cytolytic exotoxin 3.1
Spy_0182 speG Streptococcal pyrogenic exotoxin G 1.7
Spy_0282 covR Response regulator involved in regulation of expression of
virulence genes
1.8
Spy_0283 covS Histidine kinase involved in regulation of expression of
virulence genes
1.9 2.5
Spy_0668 mac Bacterial protein Mac1 3.3
Spy_0777 sclB Adhesion protein belonging to the collagen superfamily 1.7
Spy_1065 amyA Extracellular -glucan-degrading enzyme involved in virulence 2
Spy_1415 sdaD2 Streptodornase 2.1 3.3 2.8
Spy_1540 endoS Secreted endoglycosidase EndoS; modifies the IgG heavy chain 2.2
Spy_1684 ska Staphylokinase 2.4
Spy_1718 sic1.01 SIC 1.9 2.4
a The shaded rows indicate genes that are differentially regulated in the mid-logarithmic and stationary phases and at both temperatures; ME, mid-exponential growth phase; SP,
stationary growth phase.
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creased resistance to cationic antimicrobial peptides (CAMPs)
and lantibiotics that target lipid II (44–46) and (ii) higher levels of
peptidoglycan (PG) and other envelope components that also are
targets for CAMPs (47, 48).
The gene Spy_0124 (sloR), encoding a regulator involved in
metal homeostasis, was also significantly upregulated by 10.3-fold
in the fabT deletion mutant during mid-exponential phase at
35°C. Metalloregulators have been shown to modulate virulence
gene expression in S. pyogenes (49–51).
The arginine deiminase pathway genes, from Spy_1270
(arcC) to Spy_1275 (arcA), were downregulated by over 10-
fold during the mid-exponential phase of growth in the fabT
deletion mutant, but only at 35°C. Notably, this change in dif-
ferential expression was the largest found for downregulated
genes in this study.
Phenotypic analysis of the fabT deletion mutant: resistance
to polymyxin B. The infection protocol used in this study con-
sisted of 24-h intramuscular exposure in the nonhuman primate
hosts before bacteria were harvested. Because of the relatively
short time of exposure to the bacteria, we assumed that largely
innate immune processes would be operative. CAMPs made by
the host are an important part of the innate immunity repertoire.
CAMPs kill bacteria through insertion into and subsequent pore
formation in bacterial membranes (52). We hypothesized that,
compared to the wild-type parental strain, the fabTmutant would
have increased resistance to polymyxin B, an antimicrobial agent
that mimics endogenous CAMPs. Consistent with the hypothesis,
mutant strain MGAS2221fabT had significantly increased resis-
tance to polymyxin B compared to the wild-type parental strain
(Fig. 5A). Similarly, two naturally occurring representative FabT
mutants isolated from humans with invasive infections (12) had
significantly increased resistance to polymyxin B, as expected
based on the data for strainMGAS2221fabT (Fig. 5B). These two
human strains have single nucleotide insertions located early in
the fabT gene that produce frameshift mutations resulting in a
FabT-null organism (Fig. 5B).
The fabT deletion mutant strain is less virulent in an animal
model of necrotizing fasciitis. Given the number and types of
genes identified by the RNA-seq analysis to be differentially regu-
lated in the fabT mutant, we hypothesized that FabT inactivation
significantly decreases S. pyogenes virulence. A nonhuman pri-
matemodel of necrotizing fasciitis was used to test this hypothesis.
Compared to the wild-type parental strain, the isogenic mutant
strain MGAS2221fabT caused significantly less dissemination
(Fig. 6A and B), smaller lesions (Fig. 6C), and less tissue destruc-
tion (Fig. 6D). The wild-type strain caused extensive destruction
of fascia and muscle with severe myonecrosis and hemorrhage
(Fig. 6D, left), whereas the isogenic fabT mutant strain caused
only limited myocyte damage (Fig. 6D, right). Together, these
data demonstrate that fabT inactivation decreases virulence in this
animal mimetic of human necrotizing fasciitis.
Significantly decreased survival of FabT mutant bacteria in
human blood and during phagocytic interaction with human
PMNs. Two possibilities to account for the altered virulence of
isogenic mutant strainMGAS2221fabT are decreased survival
in blood and increased killing by PMNs. To test these possibil-
ities, wild-type strain MGAS2221 and isogenic mutant strain
MGAS2221fabT were compared for survival in whole human
blood and after incubation with purified PMNs. Consistent with
our idea, thefabTmutant strain had significantly decreased sur-
vival in both assays compared to thewild-type parental strain (Fig.
7A and B).
DISCUSSION
S. pyogenes modulates gene expression to adapt to and survive
conditions encountered in various host tissues (2, 53). As a con-
tinuation of our studies investigating the molecular adaptation of
the pathogen to the host environment, we investigated the
genomic landscape of mutational variation 24 h after infection in
a model of necrotizing fasciitis. The strain used is genetically rep-
resentative of serotype M1 organisms that have caused pandemic
disease in the last 30 years. Our data demonstrate repeated and
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FIG5 MGAS2221fabT shows increased resistance to polymyxinB. (A) Spot dilution assay ofwild-type strainMGAS2221 and the fabTdeletionmutant onTHY
plates containing either 0, 20, 50, or 100g/ml polymyxinB. Shown from left to right are undiluted and 101- to 105-diluted samples of amid-logarithmic phase
culture grown in THYmedium. (B) Spot dilution assay of wild-type strainMGAS2221 and strainsMGAS1253 andMGAS25770 on THY plates containing 0, 30,
80, or 150g/ml polymyxin B. The last two strains were isolated frompatients with invasive disease and contain single nucleotide insertions within the fabT gene:
MGAS1253, A15 insertion, SF370-like strain isolated around 1920 (12); MGAS25770, A106 insertion, 5005-like strain isolated in 2006 (12).
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abundant mutational inactivation of the fabT gene encoding a
regulator of fatty acid synthesis, virulence, and other genes. The
findings support previous studies showing that FabT is a tran-
scriptional regulator that directly or indirectly regulates multiple
genes assigned to many different functional categories, including
lipid and carbon metabolism and virulence.
We found that 21.8% of the 2,954 strains recovered from dis-
eased host muscle had polymorphisms (primarily one per strain),
with 45% of them apparently randomly distributed throughout
the genome. Importantly, 55% of the polymorphisms were lo-
cated in the fabT gene, which encodes a transcriptional repressor
of fatty acid biosynthesis. The mutated amino acid residues pref-
erentially occurred in predicted functional domains in the FabT
protein. Several of the amino acid changes we identified in FabT
are located in highly conserved domains present in the MarR su-
perfamily of transcriptional regulators. Most of the polymor-
phisms are predicted to result in frameshift mutations, premature
protein termination, or radical structure change. The only reason-
able explanation for the great abundance of mutations in fabT,
coupled with the inferred detrimental effect on FabT, is that this
transcriptional regulator is under strong selective pressure during
deep-seated invasive infection. Data from sequence analysis of
3,615 serotype M1 S. pyogenes genomes cultured from infected
humans are fully consistent with and support this idea (12).
We propose three potential explanations for why fabT inacti-
vation is potently selected for during invasive infection in the ex-
perimentally infected animals and diseased humans. First, it is
possible that inactivation of fabT confers beneficial consequences
for the pathogen, such as enhanced survival due to membrane
alterations. For example, it may be that membrane alterations
confer resistance to host CAMPs, which is achieved by alteration
of the acyl chains in their phospholipids (54). Consistent with this
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FIG 6 The fabT deletion strain is less virulent in a nonhuman primate model of necrotizing fasciitis. Cynomolgus macaques were inoculated intramuscularly in
the anterior thigh. (A) CFU recovered from the inoculation site in the thigh. (B) CFU recovered from the distal muscle margin near the hip. (C) Lesion size. The
error bars indicate standard errors of the mean (SEM). (D) Histopathology. The boxed region in the left micrograph shows that the wild-type strain causes
extensive fascial necrosis, muscle cell destruction, and hemorrhage at the inoculation site. The circled region in the right micrograph shows that strain
MGAS2221fabT causes less severe necrotizing fasciitis. Original magnification,4.
A B
FIG 7 The fabT deletion strain is more susceptible to blood and PMN killing
than the wild-type strain. (A) Strains were exposed to blood bactericidal activ-
ity and assayed at 0, 1, and 3 h. (B) Strains were exposed to PMNs, and bacte-
ricidal activity was assayed at 0 and 3 h. The results are means and SEM of data
from 9 separate experiments. *, P
 0.05 using a paired t test.
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idea, compared to the wild-type parental strain, we found that the
fabTmutant was more resistant to treatment with polymyxin B, a
cationic antimicrobial agent. Our result is consistent with recent
data showing that mutations in fabT render S. pyogenes more re-
sistant to polymyxin B (55). Lack of FabT could also confer on
GAS increased tolerance for acidic conditions, such as those found
in necrotic tissue.
A second possibility invokes host adaptation due to diversifi-
cation of the infecting organisms into subpopulations with signif-
icantly different physiological capacities. For example, it may be
that deleterious mutations in fabT result in subpopulations that
provide critical or otherwise limiting nutrients towild-type cells in
the necrotic host environment. SerotypeM49 GAS grown in THY
broth during the stationary phase showed similar genetic diversi-
fication (56). In that study, it was proposed that the diversification
of the M49 population into genetically different cell types was
beneficial to control the pH of the cultures (56). In addition to
GAS, other examples of metabolic diversity achieved by mutation
within a single microbial species have been reported (57–59).
A third possibility is that altered virulence factor production
between FabT-deficient and wild-type cells contributes to popu-
lation fitness. In this context, several virulence factors with genes
that are upregulated in the FabTmutant may be secreted in larger
quantities and contribute to adaptation during infection. Regard-
less, in view of our findings that inactivation of fabT in necrotizing
fasciitis apparently assists GAS survival whereas deletion of fabT
does not increase strain virulence in this infection type, we believe
further studies to dissect the role of FabT mutant cells in host-
pathogen interactions and virulence are warranted.
The primary goal of our study was to obtain new information
about S. pyogenes intrahost genetic variation and strain diversifi-
cation during invasive infection. We used a nonbiased approach
to address this knowledge gap by sequencing the genomes of 2,954
strains recovered from animals with experimental necrotizing fas-
ciitis. We previously analyzed (60) intrahost strain diversity using
targeted sequencing of the sic gene encoding the streptococcal
inhibitor of complement, an antiphagocytic and highly polymor-
phic secreted virulence factor that is under positive selection in the
host. We sequenced the sic gene from 2,000 serotype M1 colonies
obtained in one pharyngeal swab each from 20 human patients
with pharyngitis (100 colonies per patient) and discovered that
25% of the individuals had infections with two or more sic allelic
variants (60). The study documented intrahost genetic variation
in clonal derivatives of the infecting strain. The present study con-
firms the idea of intrahost genetic variation and extends it to the
full-genome level.
Extensive intrahost genetic variation has been well docu-
mented in certain RNA viruses. Although less well studied in bac-
terial pathogens, the subject has been gaining more interest in
recent years as DNA-sequencing costs decrease and technology
significantly improves. For example, sequence analysis of the ge-
nomes of 95 colonies of Staphylococcus aureus cultured at one time
point from a human patient with a perinephric abscess found an
average pairwise distance between the genomes of 7.4 SNPs (61).
Similarly, in related work (62–64), several investigators have stud-
ied bacterial genome-scale intrahost evolution over time, but in
these studies, generally only a single colony at each time point has
been analyzed (65–69).
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